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Mitochondrial stress response triggered by defects
in protein synthesis quality control
Uwe Richter1,* , Kah Ying Ng1,* , Fumi Suomi1,*, Paula Marttinen1, Taina Turunen1, Christopher Jackson2,
Anu Suomalainen2, Helena Vihinen1, Eija Jokitalo1, Tuula A Nyman3 , Marita A Isokallio4, James B Stewart4 ,
Cecilia Mancini5, Alfredo Brusco5 , Sara Seneca6, Anne Lombès7 , Robert W Taylor8, Brendan J Battersby1
Mitochondria have a compartmentalized gene expression system
dedicated to the synthesis of membrane proteins essential for
oxidative phosphorylation. Responsive quality control mecha-
nisms are needed to ensure that aberrant protein synthesis does
not disrupt mitochondrial function. Pathogenic mutations that
impede the function of the mitochondrial matrix quality control
protease complex composed of AFG3L2 and paraplegin cause a
multifaceted clinical syndrome. At the cell and molecular level,
defects to this quality control complex are defined by impairment
to mitochondrial form and function. Here, we establish the eti-
ology of these phenotypes. We show how disruptions to the
quality control of mitochondrial protein synthesis trigger a se-
quential stress response characterized first by OMA1 activation
followed by loss of mitochondrial ribosomes and by remodelling
of mitochondrial inner membrane ultrastructure. Inhibiting mi-
tochondrial protein synthesis with chloramphenicol completely
blocks this stress response. Together, our data establish a
mechanism linking major cell biological phenotypes of AFG3L2
pathogenesis and show howmodulation of mitochondrial protein
synthesis can exert a beneficial effect on organelle homeostasis.
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Introduction
Mitochondria contain a unique protein synthesis machinery devoted
to the exclusive translation of a small number of proteins encoded in
the mitochondrial genome (Ott et al, 2016). In humans, these number
only 13 hydrophobic membrane proteins, which form core subunits
of three respiratory chain complexes and the F1FO ATP synthase
required for oxidative phosphorylation. Assembly of these complexes
requires an additional 80 structural proteins encoded in the nucleus
and imported into mitochondria, so protein synthesis in the cytosol
and mitochondria needs temporal and spatial coordination. On the
mitochondrial side, protein synthesis must be tightly regulated with
complex assembly or proteolytic quality control to prevent nascent
chains from over-accumulating in the membrane.
Proteostasis within mitochondria requires a collection of com-
partmentalized chaperones and proteases that trace their evolu-
tionary origin back to alphaproteobacteria (Quirós et al, 2015). One
factor implicated in the quality control of mitochondrial protein
synthesis is a membrane-anchored AAA (ATPases Associated with
diverse cellular Activities) protease complex composed of AFG3L2
subunits. In humans, this hexameric complex affects the stability
of newly synthesized mitochondrial proteins (Zurita Rendón &
Shoubridge, 2012; Hornig-Do et al, 2012; Richter et al, 2015). In the
budding yeast, proteolytic maturation of the mitochondrial ribo-
somal protein Mrpl32 has been ascribed to this AAA protease
complex, a step required for ribosome assembly (Nolden et al, 2005).
In contrast, this mechanism is not observed in mammalian tissues
(Almajan et al, 2012). It is worth noting that site-specific proteolytic
processing of substrates appears to be incompatible with the con-
served mechanistic function of AAA proteases, which couple ATP
hydrolysis for protein unfolding with processive proteolysis of
substrates into oligopeptides (10 amino acids) (Sauer & Baker, 2011).
Thus, the effect on ribosome biogenesis is possibly indirect, perhaps,
reflecting a downstream response of mitochondrial dysfunction.
Pathogenic mutations that disrupt the AFG3L2 quality control
complex are associated with human diseases: hereditary spastic
paraplegia (HSP), spastic ataxia (SPAX5), spinocerebellar ataxia
(SCA28), and progressive external ophthalmoplegia (PEO) (Casari
et al, 1998; Di Bella et al, 2010; Pierson et al, 2011; Gorman et al, 2015).
A hallmark of these diseases, also seen in mouse models (Almajan
et al, 2012), is fragmentation of the mitochondrial membrane
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morphology, loss of mitochondrial ribosomes, and defective oxi-
dative phosphorylation. Fragmentation of mitochondrial morphol-
ogy prevents axonal trafficking in neurons (Kondadi et al, 2014) and
is considered a key cell biological event in the molecular patho-
genesis of these disorders (Ferreirinha et al, 2004). Nonetheless, the
etiology of these three distinguishing phenotypes has remained
unknown for the last 20 y.
AFG3L2 dysfunction is known to activate the metalloprotease
OMA1, triggering processing of the dynamin-related GTPase OPA1
tethered to the inner membrane releasing it into a soluble pool
(Ehses et al, 2009). This activation mechanism appears to be in-
dependent of the membrane potential (Ehses et al, 2009). Under
these circumstances, mitochondrial morphology is remodelled from
a reticular shape to a fragmented swollen state. Preventing stress-
induced OPA1 processing has been shown to be beneficial in a
mousemodel of neurodegeneration (Korwitz et al, 2016). However, no
mechanism has been established, so far, that could reconcile AFG3L2
quality control to OPA1 processing and dynamic changes in mem-
brane morphology.
In this study, we report that impaired quality control of mito-
chondrial nascent chain synthesis triggers a novel stress response
first characterized by OMA1 activation and then remodelling of
membrane ultrastructure from the reduction in mitochondrial ri-
bosomes. Together, our data establish a mechanism linking major
cell biological phenotypes of AFG3L2 pathogenesis and show how
modulation of mitochondrial protein synthesis can exert a bene-
ficial effect on organelle homeostasis.
Results
A mitochondrial stress response from impaired nascent chain
quality control
AFG3L2 dysfunction activates OMA1, inducing proteolysis of the long
OPA1 forms (membrane tethered) independently of alterations
to membrane potential (Ehses et al, 2009; Kondadi et al, 2014)
(Fig 1A–C). Recently, we showed how AFG3L2 modulated a mito-
chondrial membrane proteotoxicity arising from the small molecule
actinonin and characterized by OMA1 activation (Richter et al, 2013,
2015). The magnitude of the drug response was proportional to the
rate of translation elongation on mitochondrial ribosomes and/or
the abundance of AFG3L2. A subsequent study demonstrated acti-
nonin specifically bound to the AFG3L2 orthologue in Plasmodium
falciparum and Toxoplasma gondii (Amberg-Johnson et al, 2017),
suggesting a conserved mechanism across the eukaryotic tree.
Therefore, we asked whether the OMA1 activation associated with
AFG3L2 defects was triggered by stress arising from mitochondrial
protein synthesis. AFG3L2 siRNA leads to proteolytic cleavage of long
OPA1 and mitochondrial fragmentation (Fig 1B and D). Both phe-
notypes were robustly blocked by inhibiting protein synthesis on
mitochondrial ribosomes with chloramphenicol (Fig 1B and D).
Another prominent phenotype observed with AFG3L2 dys-
function in genetically modified mouse models is reduction in
the abundance of mitochondrial ribosomes (Nolden et al, 2005;
Almajan et al, 2012). After 5 d of AFG3L2 siRNA knockdown in human
cultured fibroblasts, there was no difference on the abundance of
the mitochondrial ribosomal protein uL11m (Fig 1B). This suggests
the ribosomal phenotypemay not be direct but rather a response to
the progressive loss of this AAA protease complex. To test the idea,
we investigated the consequences from a longer AFG3L2 siRNA
knockdown by waiting an additional three days (no extra siRNA was
added) before collecting the cells. The rationale for this approach is
that AFG3L2 is a core fitness gene (Hart et al, 2015), which impedes
the use of genome editing to make a genetic knockout in cultured
human cells. After 8 d of culture, we still observed a robust re-
duction of AFG3L2 and OPA1 processing, which is now accompanied
with a decrease in mitochondrial ribosomal proteins from both the
large and small subunit (Fig 1B). Inhibition of mitochondrial protein
synthesis with chloramphenicol completely suppressed not only
OPA1 processing but also the reduction of mitochondrial ribosomes
(Fig 1B). Together, the data indicate AFG3L2 dysfunction generated a
proteotoxicity that arose specifically from newly synthesized mi-
tochondrial proteins, triggering an organelle stress response.
Because the mitochondrial genome (mtDNA) encodes both ribo-
somal RNAs (rRNAs) essential for mitochondrial ribosome assembly,
we sought to distinguish whether the loss of the mitochondrial ri-
bosomes was simply a downstream response from a reduced mtDNA
copy number. OPA1 abundance is known to affect the copy number
and integrity of the mitochondrial genome (mtDNA) (Hudson et al,
2008). We used Southern blotting to quantify the mitochondrial copy
number and genome integrity. No differences were observed with
either short- or long-term AFG3L2 siRNA knockdown (Fig 1E and F).
Prohibitins form a scaffold in the inner membrane that physi-
cally interacts with and regulates the AFG3L2 complex (Steglich
et al, 1999; Nolden et al, 2005). Loss of the prohibitin scaffold also
triggers OMA1-dependent processing of OPA1 (Merkwirth et al,
2008). To test if mitochondrial nascent chain proteotoxicity was
the OMA1 trigger, we used siRNA against prohibitin 2 (PHB2) and
treated cells with chloramphenicol. Complete inhibition of mito-
chondrial protein synthesis with chloramphenicol blocked the
OPA1 processing (Fig S1A). In contrast, loss of the other mito-
chondrial inner membrane–bound AAA protease, YME1L, or its
scaffold STOML2 (Wai et al, 2016) did not induce a translation-
dependent OPA1 processing (Fig S1B and C). This points to a primary
importance of the AFG3L2 complex for the quality control of nascent
chains emerging from mitochondrial ribosomes in the matrix.
Next, we addressed the relevance of the stress response with a
pathogenic mutation in AFG3L2. MEFs heterozygous for a knock-in
mutation M665R (M666R in humans) associated with spinocer-
ebellar ataxia 28 (SCA28) (Cagnoli et al, 2010; Mancini et al, 2018) did
not exhibit stress-activated OPA1 proteolysis or reduction of mi-
tochondrial ribosomal proteins at the steady state (Fig 1G). This
finding is consistent with observations from a number of human
heterozygous pathogenic mutations in AFG3L2 (Di Bella et al, 2010).
In contrast, MEFs homozygous for the M665R mutation exhibited
mitochondrial translation-dependent OPA1 processing at the steady
state (Fig 1G).
Temperature is a well-known modulator of protein folding, so
we used heat shock as a stress during mitochondrial protein
synthesis to test whether it is a modifier of the M665R Afg3l2 mu-
tation. Heat shock triggered mitochondrial translation-dependent
OPA1 processing and reduction of mitochondrial ribosomal proteins
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proportional to the allelic copy number of the pathogenic M665R
Afg3l2 mutation (Fig 1G). This effect was not observed in the wild-
type MEFs. To investigate the robustness of the finding in further
detail, we used heat shock in a series of control cell lines (wild-type
human immortalized fibroblasts, myoblasts, HEK293, and an ad-
ditional MEF line) for up to 4 h. None of these human or mouse
cultured cell lines exhibited stress-activated OPA1 processing with
heat shock (Figs S1C–E and S2D and G). Thus, heat shock appeared
to elicit a mitochondrial translation-dependent stress response
only with pathogenic mutations in AFG3L2. Collectively, our data
demonstrate that AFG3L2 has a primary role in regulating pro-
teotoxicity that arises during protein synthesis on mitochondrial
ribosomes. Absence of this quality control step activates a con-
served progressive mitochondrial stress response initiated on the
inner membrane.
Aberrant mitochondrial mRNA triggers a translation-dependent
stress response
Next, we set out to investigate the source of the proteotoxicity that
arises during nascent chain synthesis on mitochondrial ribosomes.
Proteotoxicity could be generated by the impaired quality control of
all 13 proteins, a subset or specific nascent chains, or a type/class
of genetic mutation. Currently, it is not possible to modify open
Figure 1. A mitochondrial translation stress
response regulating OPA1 and ribosome homeostasis.
(A) Diagram illustrating the stress-induced regulated
proteolysis of membrane-tethered OPA1 by the OMA1
metalloprotease. (B) Immunoblotting of whole-cell
lysates of human fibroblasts treated with the indicated
siRNAs with (+) and without (−) chloramphenicol (CA).
*Nonspecific band detected with the AFG3L2 antibody.
(C) Scatter plot of mitochondrial membrane potential
analyzed by tetramethylrhodamine (TMRM) staining of
HEK293 cells treated with the indicated siRNAs from
independent experiments. CCCP is a positive control to
dissipate the membrane potential. Oligomycin (oligo)
inhibits the F1FO ATP synthase, which leads to
hyperpolarization unless ATP hydrolysis is required to
maintain the membrane potential. (D) Scatter plot
quantification of mitochondrial morphology under
light microscopy in human fibroblasts treated with the
indicated siRNAs with or without CA. Data are from
three independent experiments, n = 100. (E) Southern
blot of human fibroblasts treated with the indicated
siRNAs with (+) and without (−) CA. (F) Quantification of
Southern blotting in (E) from three independent
experiments. Data represent mean ± SD. (G)
Immunoblotting of mouse embryonic fibroblasts with
the indicated Afg3l2 genotypes grown at 37°C or heat
shocked for 4 h at 45°C with (+) and without (−) CA. IM,
inner membrane; S1, OMA1 proteolytic site; SC,
scrambled.
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reading frames within the human mitochondrial genome with gene
editing, so we turned to genetic mutations linked to human mi-
tochondrial disorders that disrupt the synthesis or stability of the 13
mitochondrial proteins.
Our first goal was to test whether unstable nascent chains
triggered OMA1 activation. We took several approaches to in-
vestigate this question, focusing on critical subunits required for
the assembly of individual oxidative phosphorylation complexes.
Assembly defects to the F1FO ATP synthase generate instability of
MT-ATP6 and MT-ATP8 nascent chains (Fig S2A and B). We tested a
mild and severe disruption to complex assembly (Cˇı´zˇkova´ et al,
2008; Rak et al, 2011), but neither induced OMA1 activation (Fig S2C).
Next, we turned to the two catalytic core subunits of cytochrome c
oxidase: MT-CO1 and MT-CO2. COX10 is an essential enzyme in-
volved in the biosynthetic pathway for heme a, a critical metal
moiety for cytochrome c oxidase assembly and required for stability
of MT-CO1 nascent chains (Antonicka et al, 2003). The absence of
MT-CO1 also disrupts MT-CO2 stability (Fig S2D). Genetic disruptions
to COX10 function, however, did not activate OMA1 even after heat
shock (Fig S2E). These data suggest that instability of four of the 13
nascent chains does not act as proteotoxic trigger.
To expand this line of inquiry, we asked whether a severe dis-
ruption to the synthesis and stability of all 13 nascent chains could
be an OMA1 trigger. To test this question, we used humanmyoblasts
homoplasmic for the m.8344A>G mutation in the mitochondrial
tRNALys linked to MERRF (myoclonus epilepsy, ragged-red fibers)
(Boulet et al, 1992; Sasarman et al, 2008). In these cells, there is a
severe defect to the synthesis and stability of all mitochondrial
nascent chains (Fig S2F and G) (Richter et al, 2018). However, we
observed no stress-induced OMA1 activation at the steady-state or
even following a 4-h heat shock (Fig S2G). Collectively, our data rule
out the instability of mitochondrial nascent chains as the pro-
teotoxic trigger for OMA1 activation.
Most human pathogenic mtDNA mutations occur within tRNA
genes and tend to be very rare in the protein-coding regions (Taylor
& Turnbull, 2005; Yarham et al, 2010). An exception is MT-ATP6,
which is an essential subunit of the F1FO ATP synthase (Zhou et al,
2015). We investigated whether mutations in this open reading
frame could induce the mitochondrial translation-dependent
stress response. In this collection of patient fibroblasts, there
are three different missense mutations that generate apparently
stable proteins at steady state, one nonsense mutation that leads
to reduced synthesis of the full-length MT-ATP6, and an MT-ATP6
mRNA lacking a stop codon (Fig 2A and B) (Seneca et al, 1996;
Aure´ et al, 2013; Jackson et al, 2017). At steady state, none of these
pathogenic mutations displayed stress-induced OPA1 processing
Figure 2. Heat shock during translation of an aberrant mitochondrial mRNA triggers a mitochondrial stress response.
(A) Diagram of human MT-ATP6 illustrating the location of pathogenic mutations in the protein and the heteroplasmy level of the mutations in patient fibroblasts.
(B) Immunoblotting of whole-cell lysates from patient fibroblasts with the indicated MT-ATP6 mutations and a WT control. (C) A 30-min pulse metabolic labelling with
35S-methionine/cysteine of mitochondrial protein synthesis in patient fibroblasts with the indicated MT-ATP6 mutations. (D) Immunoblotting of whole-cell lysates from
fibroblasts with the indicated MT-ATP6 mutations heat shocked for 4 h at 45°C with (+) and without (−) chloramphenicol.
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(Fig 2B). The non-stop MT-ATP6 mRNA (m.9205delTA), because of a
2-bp microdeletion, was associated with undetectable protein
synthesis (Fig 2B and C). Using high-resolution respirometry,
however, along with an oligomycin titration assay, which is a
specific enzymatic inhibitor of the F1FO ATP synthase, we could
measure a residual level of a functional complex (Fig S3). Deep
sequencing of the mitochondrial genomes in the MT-ATP6
m.9205delTA fibroblasts (Table S1) identified approximately 3%
wild-type mtDNAmolecules, which is presumably the source for the
functional MT-ATP6 that was undetectable bymetabolic labelling or
immunoblotting.
We asked whether heat shock could modulate any of the MT-
ATP6mutations and thereby activate the mitochondrial translation
stress response. To our surprise, heat shock induced OPA1 pro-
teolytic processing but only with the MT-ATP6 m.9205delTA muta-
tion (Fig 2D). Heat shock also reduced the abundance of the
mitochondrial ribosomal protein uL11m in these fibroblasts (Fig 2D).
Both phenotypes could be completely blocked when mitochondrial
protein synthesis was inhibited with chloramphenicol (Fig 2D).
Together, the data suggested that only nascent chain synthesis
from an aberrant mitochondrial mRNA during heat shock can ac-
tivate the same stress response observed with AFG3L2 dysfunction.
Next, we sought to investigate in more detail the mitochon-
drial translation-dependent stress response with the MT-ATP6
m.9205delTA mutation. Heat shock induced time-dependent pro-
cessing of OPA1 and reduction in uL11m (Fig 3A and B). Interestingly,
there is a differential decay on the reduction in the mitochondrial
rRNA, which appears to be faster for the 12S rRNA of the small
subunit (Fig 3C). Importantly, this loss of mitochondrial rRNA and
ribosomal protein is not due to alterations in the copy number of
mtDNA (Fig 3D). To generate a more comprehensive and quantitative
analysis of the changes to mitochondrial ribosomal protein abun-
dance, we used label-free quantitative liquid chromatography–mass
spectrometry/mass spectrometry. Using this method, we detected a
significant and robust loss of mitochondrial ribosomal proteins from
both the large and small subunits during heat shock in the MT-ATP6
m.9205delTA patient fibroblasts (Fig 3E). Assembly of the F1FO ATP
synthase requires subunits synthesized on both cytosolic and mi-
tochondrial ribosomes. Thus, unbalanced accumulation of newly
synthesized subunits of the complex from cytosolic ribosomes could
trigger the response in the MT-ATP6 m.9205delTA patient fibroblasts
during heat shock. To test this idea, we inhibited cytoplasmic protein
synthesis with anisomycin, a well-known inhibitor of the 80S cy-
tosolic ribosome but did not observe any modulation of the OPA1
processing phenotype (Fig 3F). Therefore, heat shock during the
translation of an aberrant mitochondrial mRNA triggers a ribosomal
decay pathway and OMA1 activation.
To address the consequence of heat shock to mitochondrial
protein synthesis, we pulse labelledmitochondrial proteins with 35S
for 30 min at different time points during a 4-h incubation (Fig 4A).
In the MT-ATP6 m.9205delTA fibroblasts, we observed a rapid at-
tenuation of mitochondrial protein synthesis during heat shock (Fig
4B) that preceded the reduction in ribosomal proteins (Fig 3B).
Because we showed AFG3L2 is integral to the quality control of
mitochondrial nascent chain synthesis (Fig 1), we asked whether a
quantitative increase in the complex abundance could modulate
the stress response in the MT-ATP6m.9205delTA fibroblasts. Stable
retroviral overexpression of the wild-type AFG3L2 cDNA in these
fibroblasts suppressed both the OPA1 processing and mitochon-
drial ribosomal phenotypes (Fig 4C). Because the complex can act
as an AAA unfoldase independently of its role in proteolysis (Arlt
et al, 1996), we sought to distinguish which function was most
important during heat shock. To this end, we used site-directed
mutagenesis to insert an E575Q mutation in the HEXXH motif of
the AFG3L2 protease domain, although the protein still retains a
functional AAA domain. A quantitative increase in the AAA function
of AFG3L2 was epistatic to the translation of the m.9205delTA
mutation during heat shock, suppressing both the OPA1 and the
mitochondrial ribosomal phenotypes indistinguishably from the
wild-type cDNA (Fig 4C). In contrast, AFG3L2 overexpression had no
effect on the rapid attenuation of mitochondrial protein synthesis
during heat shock (Fig 4D). Taken together, our findings revealed
proteotoxicity arising from the translation of an aberrant mito-
chondrial mRNA and AFG3L2 dysfunction. The ability of the AFG3L2
complex to unfold these nascent chain substrates appears to be a
critical modulator of this proteotoxicity arising from mitochondrial
gene expression.
Remodelling of lamellar cristae due to inhibition ofmitochondrial
protein synthesis
The OPA1 stress-induced proteolytic processing associated with
AFG3L2 dysfunction has been linked to alterations in cristae
morphology (Merkwirth et al, 2008; Ehses et al, 2009; MacVicar &
Langer, 2016). However, our data clearly demonstrated this mito-
chondrial quality control step is also integrated with mitochondrial
gene expression. Because the respiratory chain complexes and the
F1FO ATP synthase are localized within cristae (Rabl et al, 2009),
biogenesis of these membrane invaginations is predicted to be
coupled to the synthesis and assembly of the oxidative phos-
phorylation complexes. Therefore, we sought to distinguish primary
versus potential feedback responses in cristae morphogenesis among
these various factors. The ability to block OPA1 stress-activated
Figure 3. Heat shock during translation of an aberrant mitochondrial mRNA activates OMA1 and a ribosome decay pathway.
(A) Immunoblotting of whole-cell lysates from the MT-ATP6 m.9205delTA fibroblasts. (B) Left, immunoblotting of whole-cell lysates from the MT-ATP6 m.9205delTA
fibroblasts. Right, quantification of the immunoblotting from three independent experiments. Data represent mean ± SD. (C) Left, representative images of Northern
blotting of total cellular RNA from MT-ATP6 m.9205delTA fibroblasts. Right, quantification of the Northern blotting from four independent experiments. Data represent
mean ± SD. (D) A representative image of Southern blotting for mitochondrial DNA copy number from the MT-ATP6 m.9205delTA fibroblasts from multiple independent
experiments. (E) Quantitative label-free liquid chromatography–mass spectrometry/mass spectrometry analysis of mitochondrial ribosomal subunits from the large
(LSU) and small (SSU) subunit of wild-type and MT-ATP6 m.9205delTA fibroblasts grown at 37°C or heat shocked for 4 h at 45°C. Each data point represents a single
mitochondrial ribosomal protein. Data were collected from isolated mitochondria from five independent experiments for each genotype and temperature condition.
(F) Immunoblotting of whole-cell lysates of human fibroblasts with the indicated MT-ATP6 genotypes following culture at 37°C or heat shocked for the indicated time at
45°C treated with the indicated translation inhibitors. Anisomycin inhibits translation elongation on cytoplasmic ribosomes.
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processing with chloramphenicol (Figs 1, 2, 3, and 4) provided a
robust tool to investigate the question.
In human fibroblasts, mitochondrial cristae appear as lamellar
sheets with single ormultiple crista junctions, either circular or slot-like
in shape, when imaged in situ with electron tomography and 3D
modelling (Fig 5A–C, Video 1). Dimerization of the F1FO ATP synthase
generates positive curvature along cristae (Rabl et al, 2009; Davies et al,
2012). However, only with a severe assembly defect in the complex (e.g.,
ATP5B siRNA) did we observe a robust alteration in cristae morphology
in transmissionelectronmicrographs (Figs S2AandB, S3, andS4A),which
appears similar to that seen with dimerisation defects (Rabl et al, 2009;
Harner et al, 2016). In contrast, milder assembly defects or pathogenic
MT-ATP6 mutations associated with human disease had lamellar
cristae (Figs 5A–C, S2A andB, S3, S4B–D, andVideo 1 and 2). Apparently, a
low level of a functional F1FO ATP synthase (Fig S3) is sufficient to
maintain cristae curvature (Figs 5A and C, S4, and Video 1 and 2).
Figure 4. Translation of an aberrant mitochondrial mRNA negatively regulates protein synthesis during heat shock.
(A) A schematic illustrating the experimental workflow for 35S-methionine/cysteine metabolic labelling for mitochondrial protein synthesis during heat shock. All cells
were pulse labelled with 35S-methionine/cysteine for 30 min to measure mitochondrial protein synthesis following the indicated incubation times at 45°C. (B) Top,
a representative metabolic labelling with 35S-methionine/cysteine during heat shock in human fibroblasts with the indicatedMT-ATP6 genotypes. Below, quantification of
35S-incorporation intomitochondrial proteins during heat shock. Data represent mean + SD from four independent experiments. a.u., arbitrary units. (C) Human fibroblasts
with theMT-ATP6m.9205delTA genotype were stably transduced by retrovirus with an empty vector, wild-type AFG3L2 or E575Q AFG3L2 cDNA. Immunoblotting of whole-cell
lysates from cells heat shocked for 4 h at 45°C. *Nonspecific band detected with the AFG3L2 antibody. (D) Quantification of 35S-incorporation into mitochondrial
proteins in human fibroblasts with theMT-ATP6m.9205delTA genotype (from C). Data represent mean ± SD from four independent experiments. All data are representative
of multiple independent experiments.
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In contrast, AFG3L2 siRNA induced mitochondrial swelling and
disrupted the ordered lamellar ultrastructure: sheets collapsed,
appearing as swollen tubes (Fig 5A–C and Video 3 and 4). Of note,
tubular cristae still had intact circular junctions indistinguishable
from those of wild-type (Fig 5B and C) even with a robust loss of the
long membrane-tethered OPA1 forms (Fig 1B). Chloramphenicol
blocks the stress-induced OPA1 processing and mitochondrial
fragmentation associated with AFG3L2 dysfunction (Fig 1B and D),
but yet, we still observed remodelling of the inner membrane into
short stubby cristae tubules and rings (Fig 6A). In fact, the inhibition
of mitochondrial protein synthesis with chloramphenicol alone in
wild-type fibroblasts dramatically remodelled the inner membrane
without organelle fragmentation (Figs 1D and 6A). Short stubby
cristae tubules were not observed with specific defects to the
assembly of the F1FO ATP synthase (Fig S4). Thus, a robust alteration
in cristae morphogenesis appeared to arise with a global reduction
in mitochondrial protein synthesis independent of OPA1 processing.
This remodelling event could possibly serve as a feedback response
to membrane biogenesis from defective assembly of all four oxi-
dative phosphorylation complexes (I, III, IV, and V).
To further test this hypothesis, we examined the mitochondrial
ultrastructure in two established cases with severe combined oxi-
dative phosphorylation deficiencies but lacking stress-induced OPA1
processing: the mtDNA m.8344A>G tRNALys mutation and C12orf65
deficiency. In myoblasts homoplasmic for the m.8344A>G tRNALys
mutation, we observed short stubby cristae that appeared as tubules
and not lamellar sheets compared with myoblasts with the same
nuclear background but wild-type mtDNA (Fig 6B). Furthermore, in
human fibroblasts with C12orf65 deficiency (Antonicka et al, 2010), we
also observed a similar cristae phenotype that was restored to la-
mellar sheets following functional complementation with retroviral
expression of the wild-type C12orf65 cDNA (Fig 6C).
Last, we addressed how heat shock to the MT-ATP6 m.9205delTA
fibroblasts affected mitochondrial morphology and ultrastructure. A
4-h heat shock did not induce mitochondrial fragmentation or al-
terations in the inner membrane ultrastructure (Fig 6D and E) even
with robust stress-induced OPA1 processing (Figs 2D, 3A and F, and
4C). This would indicate that additional signals to the actual pro-
teolytic processing of OPA1 are required during heat shock to trigger
mitochondrial fragmentation. Our findings indicate how mitochon-
drial protein synthesis per se is a major functional determinant for
cristae morphogenesis. Thus, any organelle stress response that
impinges globally upon mitochondrial gene expression will initiate
remodelling of the inner membrane ultrastructure.
Discussion
Proteotoxicity has long been considered a key factor in the mo-
lecular pathogenesis of mitochondrial dysfunction in human dis-
ease, but the sources and origin of the offending toxic substrates
have remained unclear. Here, we demonstrated how disruptions to
mitochondrial nascent chain quality control act as a proteotoxic
trigger, initiating a stress response that links inner membrane
ultrastructure and ribosome homeostasis. These are key features
observed at the cell biological level in human patients and animal
models with pathogenic mutations in AFG3L2 or SPG7 (Casari et al,
1998; Nolden et al, 2005; Almajan et al, 2012). Our data also establish
the hierarchy to these molecular events, arising from the pro-
gressive failure in the quality control of mitochondrial nascent
chain synthesis. Our findings did not identify the specific type of
mitochondrial nascent chain proteotoxicity that occurs with AFG3L2
dysfunction. However, we provided experimental evidence by which
the translation of a specific class of aberrant mitochondrial mRNA
also activates the same stress response pathway. Thus, the pro-
teotoxic trigger with AFG3L2 dysfunction may arise during trans-
lation of aberrant mitochondrial mRNAs. Currently, we have little
understanding on the frequency by which mistakes are gener-
ated during the nucleolytic processing of the mitochondrial
polycistronic RNA messages. Presumably, these errors in gene
expression are resolved quickly by RNA surveillance mechanisms
(Keiler, 2015) so as not to activate an organelle stress response. To
test this attractive hypothesis requires experimentation beyond the
scope of the present study but promises to be an exciting avenue of
future research.
Mitochondrial dysfunction generates a heterogeneous collection
of clinical disorders that cannot be explained simply by a defect in
oxidative phosphorylation (Suomalainen & Battersby, 2018). Un-
derstanding the specific molecular defects and ensuing stress
responses is likely key to the pathogenesis. To this end, it is perhaps
not surprising that we found only a single class of additional
pathogenic mutation (MT-ATP6 m.9205delTA) that activated the
mitochondrial translation stress response, but only following the
stress of heat shock. Acute febrile infections are a critical event in
the natural history of mitochondrial disorders (Thorburn et al, 2003;
Magner et al, 2015). It could be argued the heat stress used in our
experiments is high, but it is important to point out that we used
cultured human skin fibroblasts, not neurons, which would be
exposed to such temperatures under physiological conditions
across the globe. Interestingly, the chaperone function of the AAA
domain in the AFG3L2 complex, and not the proteolytic capacity,
was critical for resolving the stress response initiated by nascent
chain synthesis of the MT-ATP6 m.9205delTA during heat shock.
Other mitochondrial AAA protease complexes, such as CLPXP,
also have a distinct chaperone role independently of proteolytic
function (Kardon et al, 2015). Collectively, the findings of this study
demonstrated how modulating the rate of mitochondrial protein
synthesis in a context-specific case can be beneficial to organelle
homeostasis and cell fitness. Such an approach may be an avenue
to develop for patients with AFG3L2 and SPG7 mutations.
Numerous studies have established OPA1 as a central factor for
the dynamics and ultrastructure of mitochondrial membranes with
Figure 5. AFG3L2 dysfunction remodels mitochondrial inner membrane ultrastructure.
(A) Representative transmission electron micrographs of human fibroblasts with the indicated MT-ATP6 genotypes treated with siRNAs. SC, scrambled sequence.
(B) Mitochondrial inner membrane morphology by electron tomographic models from three perspectives in wild-type control human fibroblasts treated with the
indicated siRNAs. Numbers indicate the position of cristae junctions along a single crista invagination in different orientations. (C) Same as (B) but in human fibroblasts
with the indicated MT-ATP6 genotype. IMS, intermembrane space.
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the proteolytic processing of the membrane-tethered form pro-
posed as a key regulator step (Friedman & Nunnari, 2014; MacVicar
& Langer, 2016). An outstanding question, however, remains on
what is a direct function of OPA1 in cristae morphogenesis from an
indirect or downstream response. Because OPA1 proteolytic pro-
cessing is associated with pleiotropic phenotypes, it is important
to resolve this distinction. Our data revealed dynamic cross-talk
between OPA1 and mitochondrial protein synthesis, suggesting
that many functions attributed to the stress-induced proteolytic
processing of OPA1 could also be due to altered protein synthesis
by mitochondrial ribosomes. Moreover, our electron tomograms of
mitochondria in situ demonstrated OPA1 proteolytic processing is
not accompanied with alterations to the cristae junctions or acute
changes to the inner membrane ultrastructure. This is in contrast to
observations from experiments with isolated mitochondria using
the proapoptotic inducer BID (Frezza et al, 2006). Therefore, the long
membrane-tethered OPA1 does not appear to play a strict role
in cristae junction formation in all cases, suggesting the general
applicability of this model should be reconsidered andmay only be
relevant to dying cells or isolated mitochondria.
Currently, the proximity of OPA1 and OMA1 to the sites of mi-
tochondrial protein synthesis is not known, but the apparent tight
coupling between these systems suggests a physical juxtaposition.
Severing the OPA1 membrane tether appeared to correlate with a
loss of mitochondrial gene expression in many cases. However,
when the AFG3L2 E575Q mutant was overexpressed in the MT-ATP6
m.9205delTA background, we blocked OMA1 activation and ribo-
some decay but not the attenuation in mitochondrial protein
synthesis associated with heat shock, suggesting that the OPA1
stress-induced proteolytic processing is not a regulatory switch for
mitochondrial gene expression. Thus, the physiological rationale
for this regulatory event remains unknown. The bulk of the in-
vestigations into the regulation of OMA1 activation have used ec-
topic addition of agents such as CCCP (Ishihara et al, 2006; Ehses
et al, 2009; Head et al, 2009; Baker et al, 2014); however, these
compounds are severely toxic to cells, producing a cellular state of
a magnitude neither physiological nor relevant to human disease.
The use of these compounds will not reveal the endogenous signals
that trigger this key regulatory event in mitochondrial homeostasis.
Future work should seek to determine the functional interplay
between OPA1 and mitochondrial gene expression because our
data robustly demonstrated failures in the quality control of na-
scent chain synthesis is a major OMA1 trigger.
Activation of the mitochondrial translation stress response in-
duced mitochondrial ribosome decay. Previously, we showed how
protein over-accumulation and dissipation of the membrane po-
tential also induced mitochondrial rRNA and mRNA decay (Richter
et al, 2013, 2015) but occurred on a slower time scale than we
observed in the MT-ATP6m.9205delTA patient fibroblasts with heat
shock. Mammalianmitochondrial ribosomes are composed ofmore
than 80 individual proteins, two rRNAs, and a tRNA (Amunts et al,
2015; Greber et al, 2015) and require a plethora of factors to co-
ordinate assembly many of which are now being discovered (Ott
et al, 2016; Brown et al, 2017). Our data provide an example of
organelle dysfunction that triggers a degradation process specific
to mitochondrial ribosomes and show the relevance of this decay
as a molecular mechanism in the pathogenesis of human disease.
These matrix localized degradation pathway(s) will be independent
of processes that involve large-scale organelle turnover, such as
mitophagy, because we did not observe any changes to mito-
chondrial DNA copy number or core import machinery (e.g., TOM40)
that are degraded in Parkin-mediated mitophagy (Yoshii et al, 2011).
In the cytosol, ribosome degradation is mediated by RNA surveil-
lance pathways following severe aberrations in translation elon-
gation (Lykke-Andersen & Bennett, 2014). Themechanisms for these
processes in mitochondria are largely unknown but open up an
exciting avenue for future research.
Materials and Methods
Cell culture
Human and mouse fibroblasts, and cell lines were cultured at 37°C
and 5% CO2 in Dulbecco’s modified Eagle’s medium (Lonza) with
high glucose supplemented with 10% fetal bovine serum, 1× glu-
tamax, and 50 μg/ml uridine. All primary cells were immortalized by
expressing E7 and hTERT (Lochmüller et al, 1999) unless previously
immortalized by the donating laboratory. All cells tested negative
for mycoplasma infection (PromoKine). Human myoblast cultures
(kind gift from Eric Shoubridge) were grown in myoblast medium
from Lonza. Chloramphenicol (Sigma-Aldrich) was used at a dose of
400 μg/ml. Heat shock was administered by adding pre-warmed
media to the plate and immediate transfer to an incubator set at
45°C. In the case of chloramphenicol treatment, the cells were
treated for 72 h before andduring heat shock. Stealth siRNAs (Thermo
Fisher Scientific: AFG3L2, HSS116886, 59-GAGUAGUAGACAGAUUGGAA-
GUCGU; Atp5b, MSS202262, 59-GAUCACCUCGGUGCAGGCUAUCUAU;
PHB2-1, HSS117606, 59-ACGAUCGCCACAUCACAGAAUCGUA; PHB2-2,
HSS117604, 59-CCAAAGACCUACAGAUGGUGAAUAU; STOML2,
HSS121274, 59-GCCUCCGUUAUGAGAUCAAGGAUAU; TMEM70, HSS123635,
59-CGAGUCUGAUUGGCCUUACAUUUCU; and scrambled control,
12935300) were transfected on day 1 and 3 with Lipofectamine
RNAiMAX (Thermo Fisher Scientific) and collected on day 8 for
analysis unless indicated otherwise. All siRNA knockdowns were
evaluated by immunoblotting using specific antibodies. Retrovirus
was generated by transient transfection of retroviral plasmids into
Figure 6. Global defects to mitochondrial protein synthesis remodels cristae ultrastructure.
(A) Representative transmission electron micrographs of human fibroblasts treated with the indicated siRNAs with or without chloramphenicol (CA). (B) Representative
transmission electronmicrographs of humanmyoblasts with the same nuclear genetic background that are either homoplasmic for wild-type mitochondrial DNA (mtDNA)
or the m.8344A>G tRNALys mutation. (C) Representative transmission electron micrographs of human fibroblasts from a patient with a pathogenic mutation in C12orf65
stably transduced with an empty vector or the wild-type C12orf65 cDNA. Bottom right, immunoblotting of whole-cell lysates with the indicated antibodies. (D)
Representative transmission electron micrographs of human fibroblasts with the MT-ATP6 m.9205delTA mutation heat shocked for 4 h at 45°C. (E) Scatter plot
quantification of mitochondrial morphology under light microscopy in human fibroblasts with theMT-ATP6m.9205delTA mutation grown at 37°C or heat shocked for 4 h at
45°C with or without CA. Data are from three independent experiments. SC, scrambled sequence.
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the Phoenix amphotropic packaging line. The cells were used di-
rectly in experiments following selection with puromycin or
blasticidin.
Cloning
Wild-type cDNAs (AFG3L2, clone BC065016; COX10, clone BC000060)
were obtained from the ORFeome or Mammalian Genome Col-
lection. These cDNAs were in a Gateway entry vector (pENTR221 or
pCMV-SPORT6) or cloned into pDONR201 using PCR with KAPA HiFi
followed by recombination. All full-length cDNAs were recombined
into Gateway-converted pBABE-puro and pMXs-IRES-Blasticidin
with LR Clonase II (Thermo Fisher Scientific). All cDNAs were thor-
oughly sequenced by Sanger sequencing for verification initially
and after all PCR manipulations. Site-directed mutagenesis of
E575Q in AFG3L2 was performed using Agilent primer design with
PCR (KAPA HiFi), purification, DpnI (NEB) digest, and transformation
into XL1 Blue chemically competent cells. Sanger sequencing was
used to validate mutagenesis. Mutant cDNA was recombined into
Gateway-converted pBABE-puro and pMXs-IRES-Blasticidin with LR
Clonase II.
Immunoblotting
Cells were solubilized in phosphate-buffered saline, 1% dodecyl-
maltoside (DDM), 1 mM PMSF, and complete protease inhibitor
(Thermo Fisher Scientific). Protein concentrations were measured
by the Bradford assay (Bio-Rad). Equal amounts of proteins were
separated by Tris-glycine SDS–PAGE and transferred to nitrocel-
lulose by semi-dry transfer or by Tricine-SDS–PAGE onto poly-
vinylidene difluoride for proteins smaller than 20 kD (Scha¨gger,
2006). Membranes were blocked in Tris-buffered saline, 0.1% Tween
20 (TBST) with 1%milk at room temperature for 1 h and then primary
antibodies were incubated overnight at +4°C in 5% BSA/TBST
and detected the following day with secondary HRP conjugates
(Jackson ImmunoResearch) using ECL with film. Primary antibodies
from Proteintech Group: AFG3L2 (14631-1-AP, 1:5,000); ATP5B (17247-
1-AP, 1:5,000); uL11m (15543-1-AP, 1:20,000); bS18b (16139-1-AP, 1:
2,000); mS26 (15989-1-AP, 1:5,000); mS27 (17280-1-AP, 1:5,000); MT-
ATP6 (55313-1-AP, 1:2,000); MT-CYB (55090-1-AP, 1:1,000); PHB2
(66424-1-Ig, 1:5,000); STOML2 (10348-1-AP, 1:5,000); and TMEM70
(20388-1-AP, 1:5,000). Primary antibodies from Abcam/Mitosciences:
MT-CO1 (1D6E1A8, 1:500) and SDHA (C2061/ab14715, 1:10,000), and
primary antibody from Santa Cruz: TOM40 (sc-11414, 1:5,000).
Representative data of independent experiments were cropped
in Adobe Photoshop with only linear corrections to brightness
applied.
TMRM staining
HEK293 cells were treated with siRNAs against AFG3L2 and
scrambled sequence then stained with 200 nM TMRM (Life Tech-
nologies). For a positive control, the cells were treated with CCCP
(10 μM). After TMRM staining, the cells were analyzed by flow
cytometry (Accuri C6, Becton Dickinson or a BD LSR II). Independent
experiments were performed and quantified. All siRNA experiments
were subsequently validated by immunoblotting.
Metabolic labelling of mitochondrial protein synthesis
Mitochondrial protein synthesis was analyzed by metabolic la-
belling with 35S methionine/cysteine (Richter et al, 2015). The cells
were pretreated with anisomycin (100 μg/ml) to inhibit cytoplasmic
translation then pulsed with 200 μCi/ml 35S Met–Cys (EasyTag-
Perkin Elmer). In chase experiments, the cells were pulsed for
30 min with radiolabel then the medium removed and replaced
with fresh medium lacking the radioisotope for the indicated time.
Equal amounts of sample protein were first treated with Benzonase
(Thermo Fisher Scientific) on ice and then resuspended in 1×
translation loading buffer (186 mM Tris-Cl, pH 6.7, 15% glycerol, 2%
SDS, 0.5 mg/ml bromophenol blue, and 6% β-mercaptoethanol).
12%–20% gradient Tris-glycine SDS–PAGE gels were used to sepa-
rate the samples and then dried for exposure with a phos-
phoscreen and scanned with a Typhoon 9400 or Typhoon FLA 7000
(GE Healthcare) for quantification. The gels were rehydrated in
water and Coomassie stained to confirm loading.
Mass spectrometry analysis
Mitochondria were isolated (QIAGEN) from control andm.9205delTA
MT-ATP6 fibroblasts cultured at 37°C or following a 4-h heat shock
at 45°C. Mitochondria were lysed (PBS, 1% DDM, 1 mM PMSF, and
complete protease inhibitor [Thermo Fisher Scientific]) on ice for
20 min and then centrifuged at 20,000 g for 20 min at +4°C. In-
soluble materials were discarded and proteins in the supernatant
were precipitated with acetone.
The protein pellet was dissolved in ProteaseMax (Promega) in
50 mM NH4HCO3, and the proteins were reduced, alkylated, and in-
solution digested with trypsin (Promega) according to the manu-
facturer’s instructions. Peptides were desalted and concentrated
before mass spectrometry by the STAGE-TIP method using a C18
resin disk (3M Empore). The peptides were eluted twice with 0.1%
formic acid/50% ACN, dried, and solubilized in 7 μl 0.1% formic acid
for mass spectrometry analysis. Each peptide mixture was analyzed
on an Easy nLC1000 nano-LC system connected to a quadrupole
Orbitrap mass spectrometer (QExactivePlus; Thermo Electron)
equipped with a nanoelectrospray ion source (EasySpray/Thermo
Fisher Scientific). For the liquid chromatography separation of the
peptides, we used an EasySpray column capillary of 25 cm bed
length (C18, 2 μm beads, 100 A˚, 75 μm inner diameter, Thermo). The
flow rate was 300 nl/min, and the peptides were eluted with a
2%–30% gradient of solvent B in 60min. Solvent A was aqueous 0.1%
formic acid and solvent B 100% acetonitrile/0.1% formic acid. The
data-dependent acquisition automatically switched between MS
andMS/MSmode. Survey full scan MS spectra were acquired from a
mass-to-charge ratio (m/z) of 400 to 1,200 with the resolution R =
70,000 at m/z 200 after accumulation to a target of 3,000,000 ions in
the quadruple. For MS/MS, the 10 most abundant multiple-charged
ions were selected for fragmentation on the high-energy collision
dissociation cell at a target value of 100,000 charges or maximum
acquisition time of 100 ms. The MS/MS scans were collected at a
resolution of 17,500. Target ions already selected for MS/MS were
dynamically excluded for 30 s.
The resulting MS raw files were submitted to the MaxQuant
software version 1.6.1.0 for protein identification using the
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Andromeda search engine. The UniProt human database (October
2017) was used for database searches. Carbamidomethyl (C) was set
as a fixed modification, and protein N-acetylation and methionine
oxidation were set as variable modifications. First search peptide
tolerance of 20 ppm and main search error 4.5 ppm were used.
Trypsin without proline restriction enzyme option was used, with
two allowed miscleavages. The minimal unique + razor peptides
number was set to 1, and the allowed false discovery rate was 0.01
(1%) for peptide and protein identification. Label-free quantitation
() was used with default settings. Known contaminants as provided
by MaxQuant and identified in the samples were excluded from
further analysis. Statistical analysis was performed with Perseus
software version 1.5.6.0. The label-free quantitation data were log10
transformed, filtered to include only proteins, which were quan-
tified in at least in three of five replicates in at least one group, and
missing values were imputed with values representing a normal
distribution with default settings in Perseus. To find statistically
significant differences between the groups, t test was performed
using permutation-based false discovery rate with 0.05 cut off
(Tyanova et al, 2016a, 2016b). The MS data are available in the PRIDE
database under accession number PXD012416.
Southern blotting
Total DNA was isolated from cultured fibroblasts as described in
QIAamp DNA Mini Kit (QIAGEN). DNA (5 μg) was digested with PvuII,
then separated on a 0.8% agarose gel followed by alkaline transfer
to Hybond-XL membrane (GE Healthcare). Two oligonucleotide
probes for mtDNA (59-GGCTCCAGGGTGGGAGTAGTTCCCTGC; 59-
CCTCCCGAATCAACCCTGACCCCTCTCC) and three for 18S rDNA (59-
GGCCCGAGGTTATCTAGAGTCACC; 59-TATTCCTAGCTGCGGTATCCAGGC;
and 59-ACCATCCAATCGGTAGTAGCGACG) were 59 end labelled with
γ 32P ATP by T4 polynucleotide kinase (NEB) and hybridized (50%
formamide, 7% SDS, 0.25M sodium phosphate, pH 7.2, 10 mM EDTA,
pH 8.0, 0.24M NaCl2) overnight at 37°C. Membranes were washed
once with 2× SSC/0.1%SDS for 60min, followed by 0.5× SSC/0.1% SDS
for 60 min, and finally in 0.1× SSC/0.1% SDS for 30 min. All washings
were performed at 37°C. The membranes were dried and then
exposed to a Phosphoscreen (GE Healthcare) and scanned with a
Typhoon 9400 (GE Healthcare).
Northern blotting
Total cellular RNAwas isolated using Trizol (Invitrogen) according to
the manufacturer’s instructions. For all samples, 5 μg of total RNA
was run through 1.2% agarose-formaldehyde gels and transferred
to Hybond-N+ membrane (GE Healthcare) by neutral transfer. T4
polynucleotide kinase (NEB) 59-radiolabelled oligonucleotides
were used for detection of mitochondrial transcripts. Oligonucle-
otides: 12S, 59-GTTAATCGTGTGACCGCGGTGGCTGGC; 16S,
59-GCTGTGTTATGCCCGCCTCTTCACGGG; and 18S, 59-ACCATCCAATCGG-
TAGTAGCGACG. Hybridization (25% formamide, 7% SDS, 1% BSA,
0.25M sodium phosphate, pH 7.2, 1 mM EDTA, pH 8.0, and 0.25M
NaCl2) was performed for 16–20 h at 37°C. Membranes were washed
(2× SSC/0.1% SDS) and then dried for exposure on a phosphoscreen
(GE Healthcare) and scanned with a Typhoon 9400 (GE Healthcare).
Amplicon generation and Illumina sequencing
Genomic DNA was extracted from patient cells known to contain
m.9205.delTA and wild-type control cells (Flp-In T-REx 293; Thermo
Fisher Scientific) using NucleoSpin Tissue kit (Macherey-Nagel GmbH
& Co. KG) according to the manufacturer’s instructions. Three PCR
amplicons spanning the deletion site were designed (amplicon 1
[3.90 kb] [primers 59-tgtaaaacgacggccagtCGCAAGTAGGTCTACAAGACG;
59-caggaaacagctatgaccATAGAGAGGTAGAGTTTTTTTCGTG]; amplicon 2
[3.16 kb] [primers 59-tgtaaaacgacggccagtATTCTTATCCTACCAGGCTTCG;
59-caggaaacagctatgaccAATGTTGAGCCGTAGATGCC]; and amplicon 3
[2.49 kb] [primers 59-tgtaaaacgacggccagtCCCCATACTAGT-
TATTATCGAAACC; 59-caggaaacagctatgaccGGCTTCGACATGGGCTTT])
and amplified in 20-μl reactions with Phusion High-Fidelity DNA
Polymerase (New England Biolabs). Cycling conditions were as
follows: 95°C for 1 min, 35 cycles of 95°C for 30 s, 60°C for 30 s, and
72°C for 2 min followed by 72°C for 3 min. The PCR products were
purified using NucleoSpin Gel and PCR clean-up kit (Macherey-
Nagel GmbH & Co. KG) according to the manufacturer’s instructions
including second wash step and elution twice to 15 μl of elution
buffer. Library preparations and Illumina sequencing reactions
were performed by the Max Planck-Genome-Centre Cologne, Ger-
many (http://mpgc.mpipz.mpg.de/home/).
Sequencing reads were trimmed with Flexbar v2.5 (Dodt et al,
2012) for TruSeq adapters and base call quality (default pa-
rameters except -q 28 -m 50 -ae ANY -ao 10). Reads containing
the M13 tag sequences in forward or reverse orientation were
removed by Flexbar (parameters -bo 15 -bt 2 -bu -be ANY) to
avoid primer-containing reads and highly biased coverage at the
amplicon edges. Unassigned reads (without the M13 tag) were
aligned with BWA v0.7.12-r1039 invoking mem (Li & Durbin, 2010;
Li, 2013) (parameters -T 19 -B 4 -L 5,4) to the human mito-
chondrial reference sequence (NC_012920.1). Uniquely aligned
reads (SAMtools view -q 1) were converted to bam format, sorted,
and indexed with SAMtools (Li et al, 2009). Per base coverage
was determined with bedtools v2.22.1 (Quinlan & Hall, 2010)
genomecov (parameters -split -d). Variants were detected with
Lofreq* v2.1.2 (Wilm et al, 2012) as follows. First, the indel
qualities were set by command lofreq indelqual –dindel, and
then variants were called including indels with minimum base
call quality 30 by command lofreq call-parallel –pp-threads
20 -N -B -q 30 -Q 30 –call-indels –no-default-filter. Variant results
were further filtered for minimum variant quality Phred score 70
and maximum strand bias Phred score 60 (strand bias filter
applied only if ≥85% of the variant supporting reads were on a
single strand) by command lofreq filter –no-defaults –snvqual-
thresh 70 –sb-incl-indels -B 60. Next, the variants were filtered
for minimum of 15 variant supporting reads using snpSift filter
with the expression DP*AF ≥ 15 and for minimum of three variant
supporting reads on each strand (expression DP4[2] ≥ 3 & DP4
[3] ≥ 3). Finally, only variants and indels present at positions
covered by minimum 100,000 reads and minimum variant allele
frequency (AF value) of 1% were accepted. To understand the
level of the reference genome bias, the aforementioned data
analysis steps were repeated using a reference genome con-
taining the deletion (9206.delA and 9205.delT). The detected
indel frequencies were then compared.
Mitochondrial translation stress response Richter et al. https://doi.org/10.26508/lsa.201800219 vol 2 | no 1 | e201800219 13 of 17
Isokinetic sucrose gradients
Medium from cultured cells grown on a 150-mm plate was rapidly
removed, and the cells were flash-frozen on dry ice. The plates were
immediately transferred to wet ice to thaw. The cells were washed
two times with ice-cold PBS, lysed on the plate (50 mM Tris, pH 7.2,
10 mMMg(Ac)2, 40 mMNH4Cl 100mM KCl, 1% DDM, 1 mM ATP, 400 μg/
ml chloramphenicol, and 1 mM PMSF), and transferred to a 1.5-ml
centrifuge tube for a 20-min incubation on ice. The samples were
centrifuged for 10 min at 20,000 g at 4°C. The supernatant was
loaded on top of a 16-ml linear 10%–30% sucrose gradient (50 mM
Tris, pH 7.2, 10 mM Mg(Ac)2, 40 mM NH4Cl 100 mM KCl, 1 mM ATP,
400 μg/ml chloramphenicol, and 1 mM PMSF) and centrifuged for
15 h at 4°C and 74,400 g (Beckman SW 32.1 Ti). 24 equal-volume
fractions were collected from the top for either trichloroacetic acid
precipitation for protein immunoblotting or for RNA isolation.
Light microscopy
Fibroblasts were grown on coverslips and washed several times in
PBS, fixed in 4% paraformaldehyde for 15 min, washed in PBS, then
treated with 100%methanol for 5min, and washed again in PBS. The
cells were blocked in 5% BSA/PBST (PBS + 0.1% Tween 20) and then
incubated with rabbit anti-TOM20 (sc-11414, 1:250; Santa Cruz) for 1 h
at room temperature or overnight +4°C. The cells were washed
several times in PBST before incubation with anti-rabbit Alexa 488 1:
1,000 (Life Technologies) for 1 h and then washed several times in
PBST. Coverslips were mounted with DABCO/MOWIOL on glass slides
for imaging with a Zeiss inverted microscope at room temperature
using a Plan-Apochromat 63×/1.40 Oil and slider assembly Apo-
Tome2. Images were exported into ImageJ using the Fiji plug-in to
apply brightness and contrast adjustments.
Transmission electron microscopy
Cultured cells were grown on glass coverslips and then fixed with
2% glutaraldehyde in Na-phosphate buffer, pH 7.4, for 30 min at
room temperature. After fixing, the samples were washed 3× 2 min
with Na-phosphate buffer, pH 7.4. The samples were then post-fixed
with 1% osmium tetroxide for 1 h at room temperature, dehydrated
with a graded series of ethanol (70%, 96%, and 100%), incubated
with transitional solvent acetone, and finally embedded gradually
in Epon (TAAB). Images were acquired on a Jeol JEM-1400 trans-
mission electron microscope with a Gatan Orius 1000B bottom-
mounted CCD camera.
Electron tomography and modelling
Samples were prepared as described for TEM. Dual axis tilt series
(Mastronarde, 1997) were recorded from one or consecutive
semi-thick (250 nm) sections using Tecnai FEG 20 (FEI Company)
microscope operating at 200 kV. The sections were tilted at one-
degree intervals using a high-tilt specimen holder (model 2020;
E.A. Fischione Instruments) between ±62°. Images were acquired
with SerialEM software (Mastronarde, 2005) using a 4 k × 4 k
Ultrascan 4000 CCD camera (Gatan Corporation) at nominal mag-
nification of 9,600× or 11,500×. The alignment of the tilt series and
reconstructions were done with IMOD software package (Kremer
et al, 1996) using 10-nm colloidal gold particles as fiducial markers.
Tomographic reconstructions were segmented with MIB software
(Belevich et al, 2016) and visualization was performed using Amira
(VSG, FEI Company).
High-resolution respirometry
Oxygen consumption rates were determined by substrate–
uncoupler–inhibitor titration protocols in permeabilized human
fibroblasts treated with siRNA using a high-resolution oxygraph
(OROBOROS instrument). Values of specific oxygen consumption
rates determined as pmol/(s*millions of cells) and are given as
ratios of different respiration states. Briefly, ~2 × 106 cells were
resuspended in MiR05 (0.5 mM EGTA, 3 mMMgCl2, 60 mM lactobionic
acid, 20 mM taurine, 10 mM KH2PO4, 20 mM Hepes, 110 mM
D-sucrose, and 1% fat-free BSA) and used per measurement. Ox-
ygen consumption rates weremeasured in digitonin-permeabilized
(1 μl of 8 mM per 1 × 106 cells) in the presence of pyruvate–
glutamate–malate (state 4 respiration on complex I), after addition
of ADP (state 3 respiration on complex I), succinate (state 3 res-
piration on complex I and II), FCCP titration (maximal uncoupled
respiration), and finally ascorbate with TMPD followed by azide
(complex IV activity).
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201800219.
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